Lithium Ion

Lithium Ion

SCHEMBL987072

CC(C(=O)[O-])c1cccnc1.[Li+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.49
CYP19A1 P11511 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.46
TBXAS1 P24557 2/20 0.44
CFTR P13569 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
GOPC Q9HD26 1/20 0.44
LMNA P02545 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27492286 0.83 CYP19A1 (0.52) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL6259017 0.81 AKR1C3 (0.57) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL22899009 0.81 CYP19A1 (0.51) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL575045 0.81 AKR1C3 (0.57) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
Hydrochloric Acid SCHEMBL4076278 0.80 AKR1C3 (0.56) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL30159419 0.80 CYP17A1 (0.50) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL17233832 0.80 CYP17A1 (0.50) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL27446830 0.80 AKR1C3 (0.56) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL4418464 0.80 CYP19A1 (0.54) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR
SCHEMBL17233924 0.80 CYP17A1 (0.50) CYP17A1CYP19A1SMN1; SMN2TBXAS1CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428660-B Process for producing acetic acid 国际人造丝公司 2022-02-15 CN disclosed
CN-107207392-B Process for producing acetic acid 国际人造丝公司 2021-06-08 CN disclosed
CN-108349865-B Process for producing acetic acid 国际人造丝公司 2021-05-11 CN disclosed
CN-107207391-B Process for producing acetic acid 国际人造丝公司 2020-11-06 CN disclosed
EP-3277654-B1 PROCESSES FOR PRODUCING ACETIC ACID CELANESE INT CORP (US) 2020-08-12 EP disclosed
EP-3374342-B1 PROCESSES FOR PRODUCING ACETIC ACID CELANESE INT CORP (US) 2020-07-08 EP disclosed
EP-3250545-B1 PROCESSES FOR PRODUCING ACETIC ACID CELANESE INT CORP (US) 2019-06-26 EP disclosed
EP-3374342-A1 PROCESSES FOR PRODUCING ACETIC ACID Celanese International Corporation (US) 2018-09-19 EP disclosed
US-9957216-B2 Processes for producing acetic acid CELANESE INTERNATIONAL CORPORATION (US) 2018-05-01 US disclosed
EP-3277654-A1 PROCESSES FOR PRODUCING ACETIC ACID Celanese International Corporation (US) 2018-02-07 EP disclosed
US-8455685-B2 Acetic anhydride production by way of carbonylation with enhanced reaction and flashing CELANESE INTERNATIONAL CORPORATION (US) 2013-06-04 US disclosed
US-20130102809-A1 Methanol Carbonylation Process with Rhodium Catalyst, an Iodide Salt and a Metallic Co-Catalyst Selected from Transition Metals, Indium, Strontium, Barium, Zinc, Tin and Heteropoly Acids CELANESE INTERNATIONAL CORPORATION (US) 2013-04-25 US disclosed
US-20130102810-A1 Methanol Carbonylation Process with Rhodium Catalyst and a Lanthanide Metal Co-Catalyst CELANESE INTERNATIONAL CORPORATION (US) 2013-04-25 US disclosed
US-20120183450-A1 ACETIC ACID PRODUCTION BY WAY OF CARBONYLATION WITH ENHANCED REACTION AND FLASHING SCATES MARK O (US) 2012-07-19 US disclosed
EP-2451766-A2 ACETIC ACID PRODUCTION BY WAY OF CARBONYLATION WITH ENHANCED REACTION AND FLASHING Celanese International Corporation (US) 2012-05-16 EP disclosed
US-8168822-B2 Acetic acid production by way of carbonylation with enhanced reaction and flashing CELANESE INTERNATIONAL CORPORATION (US) 2012-05-01 US disclosed
WO-2011159268-A1 CARBONYLATION PROCESS CELANESE INTERNALTIONAL CORPORATION (US) 2011-12-22 WO disclosed
US-20110021816-A1 Acetic anhydride production by way of carbonylation with enhanced reaction and flashing CELANESE INTERNATIONAL CORPORATION 2011-01-27 US disclosed
US-20110009665-A1 Acetic acid production by way of carbonylation with enhanced reaction and flashing CELANESE INTERNATIONAL CORPORATION 2011-01-13 US disclosed
WO-2011005304-A2 ACETIC ACID PRODUCTION BY WAY OF CARBONYLATION WITH ENHANCED REACTION AND FLASHING CELANESE INTERNATIONAL CORPORATION (US) 2011-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009665-A1 Acetic acid production by way of carbonylation with enhanced reaction and flashing DNMT1, SP1, ME1 CYP17A1 581/4885CYP19A1 575/4885SMN1; SMN2 4351/4885
US-20130102809-A1 Methanol Carbonylation Process with Rhodium Catalyst, an Iodide Salt and a Metallic Co-Catalyst Selected from Transition Metals, Indium, Strontium, Barium, Zinc, Tin and Heteropoly Acids CCNY, CA9, CA3 CYP17A1 1251/4885CYP19A1 2290/4885SMN1; SMN2 1677/4885
US-20110021816-A1 Acetic anhydride production by way of carbonylation with enhanced reaction and flashing CA3, CA4, CA2 CYP17A1 1249/4885CYP19A1 1057/4885SMN1; SMN2 3983/4885
US-20130102810-A1 Methanol Carbonylation Process with Rhodium Catalyst and a Lanthanide Metal Co-Catalyst ME1, MLYCD, SP1 CYP17A1 1400/4885CYP19A1 1724/4885SMN1; SMN2 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.